Toyota Motor Corporation (TMCO34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
60. 34
-0.18
-0.2974%
R$
- Market Cap
20.07 P/E Ratio
0.48% Div Yield
761 Volume
0 Eps
R$ 60.52
Previous Close Want to track TMCO34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
TMCO34 closed today lower at R$60.34, a decrease of -0.2974% from yesterday's close, completing a monthly increase of 9.769% or R$5.37. Over the past 12 months, TMCO34 stock lost -18.3712%.
TMCO34 pays dividends to its shareholders, with the most recent payment made on Dec 12, 2025.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Toyota Motor Corporation has completed 1 stock splits, with the recent split occurring on Nov 21, 2022.
The company's stock is traded on one exchange.
TMCO34 Chart
Toyota Motor Corporation (TMCO34) FAQ
What is the stock price today?
The current price is R$60.34.
On which exchange is it traded?
Toyota Motor Corporation is listed on B3.
What is its stock symbol?
The ticker symbol is TMCO34.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.48%.
What is its market cap?
As of today, no market cap data is available.
Has Toyota Motor Corporation ever had a stock split?
Toyota Motor Corporation had 1 splits and the recent split was on Nov 21, 2022.
Toyota Motor Corporation Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Stephen Bradley Saad CEO | B3 Exchange | - ISIN |
| ZA Country | 8,867 Employees | 27 Mar 2026 Last Dividend | 21 Nov 2022 Last Split | - IPO Date |
Overview
Aspen Pharmacare Holdings Limited, a pioneering force in the pharmaceutical industry, orchestrates the manufacture and global distribution of specialty and branded pharmaceutical products through its extensive network of subsidiaries. It distinctly segments its operations into Commercial Pharmaceuticals and Manufacturing. Originally established in 1850 and currently with its headquarters nestled in Durban, South Africa, Aspen Pharmacare has grown to play a pivotal role in the global pharmaceutical landscape, addressing a wide range of healthcare needs.
Products and Services
Aspen Pharmacare’s product portfolio spans across various therapeutic areas, showcasing a diversified range of pharmaceutical solutions:
- Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine: These brand names represent Aspen’s foray into anesthetics, including general, local, and regional anesthesia options, offering solutions for surgical pain management and procedural sedation.
- Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin: These brands cater to a variety of medical conditions. Circadin is utilized as a sleeping aid, addressing insomnias and sleep disorders. Eltroxin serves as a thyroid hormone replacement therapy, essential for managing hypothyroidism. Foxair offers respiratory relief for conditions like asthma through its airway dilating properties, while Imuran, an immunosuppressant, is crucial for patients undergoing organ transplants or suffering from autoimmune diseases. Maltofer provides an iron supplement solution, combatting iron deficiency anemia. Mybulen, an analgesic anti-inflammatory, assists in managing pain and inflammation, whereas Ovestin offers hormone replacement therapy, specifically tailored for menopausal symptoms.
- Active Pharmaceutical Ingredients (APIs) and Finished Dose Form Products: Beyond its bespoke brand offerings, Aspen is also instrumental in the production and distribution of active pharmaceutical ingredients, crucial for the pharmaceutical manufacturing process. It extends its expertise to finished dose form products, ensuring quality pharmaceuticals are accessible globally.
Contact Information
Address: Aspen Place
Phone: 27 31 580 8600
Website: https://www.aspenpharma.com
